ArticleBMJ open2025

Maintenance with niraparib in patients with stage III, stage IV, chemo-naïve recurrent or platinum-sensitive recurrent uterine serous carcinoma: study protocol for a phase II clinical trial.

Marina Frimer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.